Avadel Pharmaceuticals Plc (AVDL)
21.64
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
Avadel Pharmaceuticals EPS Diluted (Quarterly) : 0.0002 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2025 | 0.0002 |
| June 30, 2025 | 0.0975 |
| March 31, 2025 | -0.0509 |
| December 31, 2024 | -0.0523 |
| September 30, 2024 | -0.0273 |
| June 30, 2024 | -0.1437 |
| March 31, 2024 | -0.2982 |
| December 31, 2023 | -0.3029 |
| September 30, 2023 | -0.4058 |
| June 30, 2023 | -0.8341 |
| March 31, 2023 | -0.4819 |
| December 31, 2022 | -0.4341 |
| September 30, 2022 | -0.3347 |
| June 30, 2022 | -1.075 |
| March 31, 2022 | -0.4492 |
| December 31, 2021 | -0.3773 |
| September 30, 2021 | -0.3756 |
| June 30, 2021 | -0.3348 |
| March 31, 2021 | -0.23 |
| December 31, 2020 | -0.1934 |
| September 30, 2020 | -0.201 |
| June 30, 2020 | 0.4877 |
| March 31, 2020 | -0.0211 |
| December 31, 2019 | -0.0731 |
| September 30, 2019 | -0.2368 |
| Date | Value |
|---|---|
| June 30, 2019 | -0.2303 |
| March 31, 2019 | -0.3485 |
| December 31, 2018 | -1.722 |
| September 30, 2018 | -0.4273 |
| June 30, 2018 | -0.09 |
| March 31, 2018 | -0.32 |
| December 31, 2017 | -0.24 |
| September 30, 2017 | 0.52 |
| June 30, 2017 | 0.68 |
| March 31, 2017 | 0.61 |
| December 31, 2016 | 0.11 |
| September 30, 2016 | -0.48 |
| June 30, 2016 | -0.48 |
| March 31, 2016 | -0.15 |
| December 31, 2015 | 1.75 |
| September 30, 2015 | -0.73 |
| June 30, 2015 | -0.43 |
| March 31, 2015 | 0.27 |
| December 31, 2014 | -0.69 |
| September 30, 2014 | -0.26 |
| June 30, 2014 | -0.55 |
| March 31, 2014 | -0.94 |
| December 31, 2013 | 0.20 |
| September 30, 2013 | -0.25 |
| June 30, 2013 | -1.29 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Jazz Pharmaceuticals Plc | 2.778 |
| Perrigo Co. Plc | 0.5337 |
| GH Research Plc | -0.2276 |
| Cosmo NV | -- |
| Alkermes Plc | 0.0029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.02M |
| Revenue (Quarterly) | 77.47M |
| Total Expenses (Quarterly) | 77.45M |